HG BIOTECH CONSULTING LTD
Executive Summary
HG Biotech Consulting Ltd shows a solid financial foundation with strong liquidity and positive net assets for a startup business. The company maintains healthy cash reserves and manageable liabilities, indicating good short-term financial health. Moving forward, the focus should be on expanding revenue, managing cash flow prudently, and scaling operations strategically to ensure sustainable growth.
View Full Analysis Report →- Legal registered address
- 35 Grafton Way London England W1T 5DB Copied!
Latest financial results as of 8 October 2025- Cash in bank
- £49.52k
- Current assets
- £59.59k
- Current creditors
- £12.28k
- Shareholders funds
- £76.45k
View full financial accounts- Cash in bank
- £49.52k
- Current assets
- £59.59k
- Current creditors
- £12.28k
- Shareholders funds
- £76.45k
- Company number
- 14401562 Copied!
Accounts
Latest annual accounts were to 31 March 2024
Next annual accounts are due by 31 December 2025
Company financial year end is on 31 March 2026
Confirmation statement
Latest confirmation statement statement dated 29 August 2025
Next statement due by 12 September 2026
Nature of business (SIC)
70229 - Management consultancy activities other than financial management
Latest company documents
| Date | Description |
|---|---|
| 15/09/2515 September 2025 New | Confirmation statement made on 2025-08-29 with no updates |
| 11/07/2511 July 2025 | Change of details for Mr Pandelakis Georgiou as a person with significant control on 2025-07-11 |
| 11/07/2511 July 2025 | Director's details changed for Mr Pandelakis Georgiou on 2025-07-11 |
| 04/07/244 July 2024 | Total exemption full accounts made up to 2024-03-31 |
| 31/03/2431 March 2024 | Annual accounts for year ending 31 Mar 2024 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company